KZR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Kezar Life Sciences Inc (KZR) is not a strong buy for a beginner, long-term investor with $50,000-$100,000 available for investment. The stock lacks significant positive catalysts, has weak financial performance, and no clear trading signals from Intellectia Proprietary Trading Signals. While technical indicators show a bullish trend, the lack of strong sentiment, poor financials, and ongoing legal investigations make it unsuitable for immediate investment.
The stock shows a bullish trend with SMA_5 > SMA_20 > SMA_200 and MACD histogram above 0 (0.0584). RSI is neutral at 67.022, and the stock is trading near its resistance level of 7.496. However, the pre-market price of 7.35 suggests limited upside potential in the short term.
Bullish technical indicators such as moving averages and MACD. Stock has a 2.23% chance of increasing in the next month.
Ongoing legal investigations regarding shareholder rights and fiduciary duty breaches. Weak financial performance with declining net income (-28.05% YoY) and EPS (-28.16% YoY). No significant hedge fund or insider activity. No recent congress trading data.
In 2025/Q4, revenue remained at 0 with no growth. Net income dropped significantly to -$14.55 million (-28.05% YoY), and EPS declined to -1.99 (-28.16% YoY). Gross margin remains at 0, indicating no profitability.
No data available on analyst ratings or price target changes.
